Plain-English translation of NCT07381907 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a combination of two treatments for Parkinson's disease: a gentle electrical stimulation applied to the scalp (called transcranial direct current stimulation, or tDCS) paired with Nordic walking — a guided walking program using special poles. The researchers believe that applying this stimulation to a specific brain area while you practice Nordic walking might help improve walking speed, balance, and reduce freezing of gait (when your feet suddenly feel stuck). Half of participants will receive the active stimulation during their walking sessions, while the other half will receive a sham (fake) stimulation that feels similar but delivers no actual current.
Parkinson's disease often causes people to walk more slowly, take shorter steps, lose their balance, and experience freezing of gait — all of which can lead to falls and loss of independence. This treatment combination is designed to target the brain areas that control movement and walking while you actively practice the walking technique, which researchers believe could make the training more effective than walking alone.
You likely qualify if…
You likely don't qualify if…
You would attend the university rehabilitation clinic 3 times per week for 4 weeks (12 sessions total). At each session, you would receive either active or sham brain stimulation through electrodes on your scalp for 20 minutes while doing a 30-minute guided Nordic walking program with special poles. The walking sessions include a warm-up, technique practice, steady-paced walking at moderate effort, and a cool-down. After the 4-week program ends, you would return for a follow-up visit at 1 month to see if improvements have been maintained. The researchers will measure your walking speed, balance, and other Parkinson's symptoms at the start, end, and follow-up.
AI-generated summary from trial data · Jun 25, 2026 · Not medical advice
Brazil